Pirtobrutinib Improves PFS in Treatment-Naive CLL/SLL

by admin | Dec 16, 2025 | Health

Spread the love

The noncovalent BTKi shows highly favorable progression-free survival in previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma.
Medscape Medical News

← Twice-Yearly Asthma Biologic Gains UK Approval Malaysia Postpones Special ASEAN Meeting on Thailand-Cambodia Conflict →

Written By

Written by Albert Pham, News Curator and Blogger

Cocaine Trade Booms Despite U.S. Airstrikes and Drug Crackdown

Oct 13, 2026 | albertpham, Economy_finances, Health

The global cocaine trade continues to expand despite U.S. airstrikes against suspected smugglers. Discover why trafficking networks remain resilient.

McDonald’s Chicken and Beverage Strategy: Global Growth Plans Through 2030

Oct 12, 2026 | albertpham, Economy_finances, Health

McDonald’s is expanding its chicken menu and specialty beverages to gain market share by 2030, challenge competitors and attract more customers.

Endometriosis in Canada: Why Women Are Seeking Treatment in Mexico

Oct 12, 2026 | albertpham, Health, Travel

Canadian women are travelling to Mexico for endometriosis treatment after facing long wait times, highlighting gaps in specialist care and women’s health services.

Pirtobrutinib Improves PFS in Treatment-Naive CLL/SLL

Written By

Related Posts

Cocaine Trade Booms Despite U.S. Airstrikes and Drug Crackdown

McDonald’s Chicken and Beverage Strategy: Global Growth Plans Through 2030

Endometriosis in Canada: Why Women Are Seeking Treatment in Mexico

0 Comments

Explore More

Connect With Us

Quick Links

Legal

Stay Updated